Fifty years since the discovery of ibuprofen

Inflammopharmacology

Volumn 19, Issue 6, 2011, Pages 293-297

  Rainsford, K D ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CAFFEINE; CODEINE; CORTICOSTEROID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; IBUFENAC; IBUPROFEN; PARACETAMOL; PHENYLBUTAZONE; PROSTAGLANDIN;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; ARTHRALGIA; ARTHRITIS; CARDIOVASCULAR RISK; DISEASE ACTIVITY; DISEASE CONTROL; DRUG ACCUMULATION; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; DRUG SCREENING; DRUG SYNTHESIS; DRUG USE; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATION; LIVER TOXICITY; LOW DRUG DOSE; NEPHROTOXICITY; NONHUMAN; PAIN; PRESCRIPTION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RECOMMENDED DRUG DOSE; REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG DISCOVERY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IBUPROFEN;

EID: 84355166437     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-011-0103-7     Document Type: Review

References (36)

1. Adams SS (1987) The discovery of Brufen. Chem Br 23:1193-1195
2. SS Adams 1988 Non-steroidal anti-inflammatory drugs, plasma half-lives, and adverse reactions Lancet 2 1204 1205
3. Adams SS, Cobb R (1967) Non-steroidal antiinflammatory drugs. In: Ellis GP, West GB (eds) Progress in medicinal chemistry 5. Butterworths, London, pp 59-133
4. EM Antman JS Bennett A Daugherty C Furberg H Roberts KA Taubert American Heart Association 2007 Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association Circulation 115 1634 1642 17325246 10.1161/CIRCULATIONAHA.106.181424 (Pubitemid 46648649)
5. Beaver WT (2003) Review of the analgesic efficacy of ibuprofen. Int J Clin Pract Suppl 135:13-17 (Pubitemid 36458872)
6. Blain H, Boileau C, Lapicque F, Nédélec E, Loeuille D, Guillaume C, Gaucher A, Jeandel C, Netter P, Jouzeau JY (2002) Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use. Br J Clin Pharmacol 53:255-265
7. TM Brasky CM Velicer AR Kristal U Peters JD Potter E White 2010 Nonsteroidal anti-inflammatory drugs and prostate cancer risk in the VITamins And Lifestyle (VITAL) cohort Cancer Epidemiol Biomarkers Prev 19 3185 3188 20935064 10.1158/1055-9965.EPI-10-0942 1:CAS:528:DC%2BC3cXhsFGkur%2FI
8. TM Brasky MR Bonner KB Moysich CB Ambrosone J Nie MH Tao SB Edge BV Kallakury C Marian DS Goerlitz M Trevisan PG Shields JL Freudenheim 2011 Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype Cancer Causes Control 22 965 975 21516318 10.1007/s10552-011-9769-9
9. K Brune 2007 Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability Curr Med Res Opin 23 2985 2995 17949535 10.1185/030079907X242584 1:CAS:528: DC%2BD1cXhslOks7k%3D
10. 2 concentrations in aspirin-treated healthy adult volunteers Clin Ther 27 185 191 15811481 10.1016/j.clinthera.2005.01.011 1:CAS:528: DC%2BD2MXjtFSqur0%3D (Pubitemid 40462011)
11. EJ Greenspan JP Madigan LA Boardman DW Rosenberg 2011 Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta} Cancer Prev Res 4 161 171 10.1158/1940-6207.CAPR- 10-0021 1:CAS:528:DC%2BC3MXhvVyqu7s%3D
12. Harris RE (ed) (2002) COX-2 blockade in cancer prevention and therapy. Humana Press, NJ, Totawa
13. Higton F (1999) The pharmaceutics of ibuprofen. In: Rainsford KD (ed) Ibuprofen. A critical bibliographic review. Taylor & Francis, London, pp 55-86
14. M Hirohata K Ono A Morinaga M Yamada 2008 Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro Neuropharmacology 54 620 627 18164319 10.1016/j.neuropharm.2007.11.010 1:CAS:528:DC%2BD1cXhsVSgtLw%3D
15. WF Kean KD Rainsford IRL Kean 2008 Management of chronic musculoskeletal pain in the elderly: opinions on oral medication use Inflammopharmacology 16 53 75 18389178 10.1007/s10787-008-1623-7 1:CAS:528:DC%2BD1cXmsFGrsb0%3D
16. Kotilinek LA, Westerman MA, Wang Q, Panizzon K, Lim GP, Simonyi A, Lesne S, Falinska A, Younkin LH, Younkin SG, Rowan M, Cleary J, Wallis RA, Sun GY, Cole G, Frautschy S, Anwyl R, Ashe KH (2008) Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain 131:651-664 (Pubitemid 351294724)
17. Mahmud SM, Franco EL, Turner D, Platt RW, Beck P, Skarsgard D, Tonita J, Sharpe C, Aprikian AG (2011). Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study. PLoS One 6(1):e16412
18. Massey T, Derry S, Moore RA, McQuay HJ (2010) Topical NSAIDs for acute pain in adults. Cochr Database Syst Rev (6):CD007402
19. Nicholson JS (1982) Ibuprofen. In: Bindra JS, Lednicer D (eds) Chronicles of drug discovery, Chapter 7, vol 1. Wiley, New York, pp 149-171
20. BM Psaty CD Furberg 2005 COX-2 inhibitors-lessons in drug safety N Engl J Med 352 1133 1135 15713946 10.1056/NEJMe058042 1:CAS:528:DC%2BD2MXit1OjsLk%3D (Pubitemid 40365356)
21. Purcell H (2007) Ibuprofen and cardiovascular safety: where do we stand? J R Soc Med 100(Suppl 48):7-10 (Pubitemid 351204440)
22. Rainsford KD (1987) Introduction and historical aspects of the side effects of anti-inflammatory analgesic drugs. In: Rainsford KD, Velo GP (eds) Side effects of anti-inflammatory analgesic drugs, vol 1. MTP Press, Lancaster, pp 3-26
23. Rainsford KD (1999) History and development of ibuprofen. In: Rainsford KD (ed) Ibuprofen. A critical bibliographic review, Chapter 1. Taylor & Francis, London, pp 3-24
24. Rainsford KD (2003) Discovery, mechanisms of action and safety of ibuprofen. Intl J Clin Pract Suppl (135):3-8 (Pubitemid 36458870)
25. KD Rainsford 2009 Ibuprofen: pharmacology, efficacy and safety Inflammopharmacology 17 275 342 19949916 10.1007/s10787-009-0016-x 1:CAS:528:DC%2BD1MXhsV2mtrvP
26. Rainsford KD (2012) Ibuprofen. Pharmacology, therapeutics and side effects. Springer press, Basel and Heidelberg (in press)
27. Rainsford KD, Kean WF, Ehrlich GE (2008) Triad (GI, CV, Hepatic) composite toxicity ratings for use in assessing the overall safety of NSAIDs. Intern Med J, 38(Suppl. 2):A32 (Abstract No. ARP71)
28. Rostrom A, Dube C, Lewin G (2007) Use of aspirin and NSAIDs to prevent colorectal cancer (Internet). Agency for Healthcare Research and Quality (US), Rockville. (Available from http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book= es45 )
29. V Strand 2007 Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin? Lancet 370 2138 2151 18156036 10.1016/S0140-6736(07)61909-6 1:CAS:528:DC%2BD2sXhsVOru7nK (Pubitemid 350296305)
30. JE Sullivan HC Farrar 2011 Section on clinical pharmacology and therapeutics; committee on drugs, fever and antipyretic use in children Pediatrics 127 580 587 21357332 10.1542/peds.2010-3852
31. EJ Topol 2005 Arthritis medicines and cardiovascular events-"house of coxibs" J Am Med Assn 293 3 366 368 10.1001/jama.293.3.366 1:CAS:528:DC%2BD2MXmslegsg%3D%3D (Pubitemid 40116092)
32. KP Townsend D Praticò 2005 Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs FASEB J 19 1592 1601 16195368 10.1096/fj.04-3620rev 1:CAS:528:DC%2BD2MXhtV2nu7rJ (Pubitemid 41429517)
33. S Trelle S Reichenbach S Wandel P Hildebrand B Tschannen PM Villiger M Egger P Jüni 2011 Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis Br Med J 342 7086 10.1136/bmj.c7086
34. Volans G, Monaghan J, Colbridge M (2003) Ibuprofen overdose. Int J Clin Pract Suppl (135):54-60 (Pubitemid 36458880)
35. TJ Woodman PJ Wood AS Thompson TJ Hutchings GR Steel P Jiao MD Threadgill MD Lloyd 2011 Chiral inversion of 2-arylpropionyl-CoA esters by human α-methylacyl-CoA racemase 1A (P504S)-a potential mechanism for the anti-cancer effects of ibuprofen Chem Commun 47 7332 7334 10.1039/c1cc10763a 1:CAS:528:DC%2BC3MXnslSnt7k%3D
36. S Wynne D Djakiew 2010 NSAID inhibition of prostate cancer cell migration is mediated by Nag-1 Induction via the p38 MAPK-p75(NTR) pathway Mol Cancer Res 8 1656 1664 21097678 10.1158/1541-7786.MCR-10-0342 1:CAS:528:DC%2BC3cXhsFOjsbrM